CVS Health Q1 2020 Earnings Report
Key Takeaways
CVS Health reported an 8.3% increase in total revenues to $66.8 billion and a 28.6% increase in GAAP operating income to $3.5 billion. Adjusted EPS was $1.91, and the company generated $3.3 billion in cash flow from operations. 2020 full year EPS guidance remains unchanged.
Total revenues increased 8.3% to $66.8 billion
GAAP operating income increased 28.6% to $3.5 billion
Adjusted EPS of $1.91
Cash flow from operations of $3.3 billion
CVS Health
CVS Health
CVS Health Revenue by Segment
Forward Guidance
While acknowledging the inherent and unprecedented uncertainty surrounding the ongoing COVID-19 pandemic and its impact, the Company’s full year 2020 GAAP diluted EPS guidance range of $5.47 to $5.60, its full year 2020 Adjusted EPS guidance range of $7.04 to $7.17 and its full year 2020 cash flow from operations guidance range of $10.5 billion to $11.0 billion remain unchanged.Given the likelihood of significant variability in the impact of COVID-19 on its financial statement line items (and related ratios), the Company is withdrawing all other previously issued 2020 additional detailed guidance.
Revenue & Expenses
Visualization of income flow from segment revenue to net income